1. Home
  2. HDB vs SNY Comparison

HDB vs SNY Comparison

Compare HDB & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HDFC Bank Limited

HDB

HDFC Bank Limited

HOLD

Current Price

$26.77

Market Cap

130.3B

Sector

Finance

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$47.70

Market Cap

107.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HDB
SNY
Founded
1994
1994
Country
India
France
Employees
N/A
74846
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.3B
107.3B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
HDB
SNY
Price
$26.77
$47.70
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$58.00
AVG Volume (30 Days)
12.2M
2.9M
Earning Date
04-18-2026
04-23-2026
Dividend Yield
1.44%
3.40%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.86
Revenue Next Year
$8.77
$5.64
P/E Ratio
$18.92
$6.14
Revenue Growth
N/A
N/A
52 Week Low
$23.91
$43.32
52 Week High
$79.62
$55.73

Technical Indicators

Market Signals
Indicator
HDB
SNY
Relative Strength Index (RSI) 47.17 59.24
Support Level $23.91 $46.88
Resistance Level $37.18 $48.88
Average True Range (ATR) 0.59 0.74
MACD 0.44 0.11
Stochastic Oscillator 78.07 75.19

Price Performance

Historical Comparison
HDB
SNY

About HDB HDFC Bank Limited

HDFC Bank Ltd is an Indian bank. It operates in the following segments: Treasury, Retail banking, Wholesale banking, and Other banking business. The maximum revenue for the company is generated from its Retail banking segment, which serves retail customers through its branch network and other channels. This segment raises customer deposits and provides loans and other services to customers using different product groups. Its other operations include providing wholesale banking services to corporates, government entities, and other enterprises, generating income from its treasury operations, and performing para-banking activities such as offering credit cards, debit cards, etc. Geographically, the company generates a majority of its revenue from its operations in India.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: